David Dingli, MD, PhD

Dr. David Dingli is a hematology and internal medicine specialist at Mayo Clinicexternal link, opens in a new tab, Rochester, Minnesota and his clinical practice is devoted to patients with plasma cell disorders and chronic myeloid leukemia. He completed his Residency and Fellowship from Mayo Clinic College of Medicine. Dr. David Dingli pursued his PhD in molecular biology from Mayo Clinic College of Medicine and Science.

Dr. Dingli has experience in treating conditions like amyloidosis, monoclonal gammopathy of undetermined significance (MGUS), multiple myeloma, paroxysmal nocturnal hemoglobinuria, plasma cell disorders, POEMS syndrome, Schnitzler syndrome, and Waldenstrom macroglobulinemia.

Representative Publications:

Prognostic Significance of Holter Monitor Findings in Patients With Light Chain Amyloidosisexternal link, opens in a new tab

Primary systemic amyloidosis in patients with Waldenstrom macroglobulinemiaexternal link, opens in a new tab

Rapid assessment of hyperdiploidy in plasma cell disorders using a novel multi-parametric flow cytometry methodexternal link, opens in a new tab

Outcomes with early response to first-line treatment in patients with newly diagnosed multiple myeloma external link, opens in a new tab

Natural history of multiple myeloma with de novo del(17p) external link, opens in a new tab

In Vivo Imaging of Oncolytic Measles Virus Propagation with Single-Cell Resolutionexternal link, opens in a new tab